{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT03557671",
      "orgStudyIdInfo": {
        "id": "UP2017-Promyce"
      },
      "organization": {
        "fullName": "United Pharmaceuticals",
        "class": "INDUSTRY"
      },
      "briefTitle": "Evaluation of the Hypoallergenicity of a New Formula Based on Hydrolyzed Rice Proteins",
      "officialTitle": "Evaluation of the Hypoallergenicity of a New Formula Based on Hydrolyzed Rice Proteins (TRHF 2017) in Children With Confirmed Immunoglobulin E (IgE) or Non-immunoglobulin E-mediated Cow's Milk Allergy (CMA)"
    },
    "statusModule": {
      "statusVerifiedDate": "2020-11",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2018-08-23",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2020-09-21",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2020-09-21",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2018-05-14",
      "studyFirstSubmitQcDate": "2018-06-04",
      "studyFirstPostDateStruct": {
        "date": "2018-06-15",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2020-11-03",
      "lastUpdatePostDateStruct": {
        "date": "2020-11-04",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "United Pharmaceuticals",
        "class": "INDUSTRY"
      },
      "collaborators": [
        {
          "name": "Statitec",
          "class": "INDUSTRY"
        }
      ]
    },
    "oversightModule": {
      "isFdaRegulatedDrug": false,
      "isFdaRegulatedDevice": false
    },
    "descriptionModule": {
      "briefSummary": "The aim of this study is to show the hypoallergenicity of a new thickened rice based formula (TRHF) through a double blind placebo controlled food challenge (DBPCFC), as recommended by the American Academy of Pediatrics, in subjects with IgE-mediated CMA and in subjects with non-IgE-mediated CMA.",
      "detailedDescription": "The study is made of 2 different steps : 1st step is a double blind randomised food challenge where the new formula is compared to a placebo.\n\nThe second part of the trial consists in an open phase during which all infants will be fed with the study formula."
    },
    "conditionsModule": {
      "conditions": [
        "Cow Milk Allergy"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "CROSSOVER",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "QUADRUPLE",
          "whoMasked": [
            "PARTICIPANT",
            "CARE_PROVIDER",
            "INVESTIGATOR",
            "OUTCOMES_ASSESSOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 72,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "TRHF - Placebo",
          "type": "EXPERIMENTAL",
          "description": "Each subjects will receive both TRHF and placebo formula during the 1st part of the study",
          "interventionNames": [
            "Dietary Supplement: rice formula",
            "Dietary Supplement: placebo"
          ]
        },
        {
          "label": "Placebo - TRHF",
          "type": "PLACEBO_COMPARATOR",
          "description": "Each subjects will receive both TRHF and placebo formula during the 1st part of the study",
          "interventionNames": [
            "Dietary Supplement: rice formula",
            "Dietary Supplement: placebo"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DIETARY_SUPPLEMENT",
          "name": "rice formula",
          "description": "new rice based thickened formula",
          "armGroupLabels": [
            "Placebo - TRHF",
            "TRHF - Placebo"
          ]
        },
        {
          "type": "DIETARY_SUPPLEMENT",
          "name": "placebo",
          "description": "formula previously tolerated by the subject - only for the 1st part of the study",
          "armGroupLabels": [
            "Placebo - TRHF",
            "TRHF - Placebo"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "hypoallergenicity",
          "description": "the percentage of children tolerating the formula during the double blind placebo controlled food challenge (TRHF 2017 vs. placebo formula).",
          "timeFrame": "7 days"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Regurgitations",
          "description": "assessed through Vandenplas score ranging from 0 (=less than 2 regurgitation episodes / day) to 6 (=Regurgitation of the complete volume after each feeding)",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Vomiting",
          "description": "(on a 4 level scale)",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Abdominal pain",
          "description": "(severity on a 4 level scale)",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Bloating and gas",
          "description": "(severity on a 4 level scale)",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Stool consistency",
          "description": "assessed through Bristol Stools Form Scale from Type A ( Separate hard lumps, like nuts (hard to pass)) to Type G (Watery, not solid pieces - entirely liquid )",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Stool frequency",
          "description": "(number of stool per day or per week)",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Blood in stools",
          "description": "(presence/absence)",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Sleeping time over 24h satisfaction",
          "description": "(presence/absence)",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Unexplained crying",
          "description": "(yes/no)",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Respiratory symptoms",
          "description": "(severity on a 4 level scale)",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Urticaria",
          "description": "(presence/absence)",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Angioedema",
          "description": "(presence/absence)",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Eczema",
          "description": "severity assessed through SCORAD",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Weight",
          "description": "expressed in kg and in z scores according to the World Health Organization (WHO) Child Growth Standards",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Height",
          "description": "expressed in cm and in z scores according to the WHO Child Growth Standards",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "BMI",
          "description": "expressed in value and z scores according to the WHO Child Growth Standards",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Head circumference",
          "description": "expressed in cm and in z scores according to the WHO Child Growth Standards",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        },
        {
          "measure": "Number of patients with treatment emergent Adverse Events",
          "timeFrame": "1, 2, 3, 4, 5 and 6 months"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* with suspected CMA or with a CMA diagnosed by a DBPCFC performed in the last 2 months prior to inclusion\n* free of clinical allergic symptoms for at least one week (i.e. successfully fed an elimination diet);\n* whose parents signed the informed consent\n\nExclusion Criteria:\n\n* mainly breast fed, drinking less than 250ml of formula/day, presenting any situation, which, according to the investigator, may interfere with the study participation or lead to a particular risk for the subject",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "1 Month",
      "maximumAge": "36 Months",
      "stdAges": [
        "CHILD"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Roberto Berni Canani",
          "affiliation": "University Federico II",
          "role": "STUDY_DIRECTOR"
        }
      ],
      "locations": [
        {
          "facility": "CHR Namur",
          "city": "Namur",
          "country": "Belgium",
          "geoPoint": {
            "lat": 50.4669,
            "lon": 4.86746
          }
        },
        {
          "facility": "HÃ´pital Saint Vincent de Paul - GHICL",
          "city": "Lille",
          "zip": "59000",
          "country": "France",
          "geoPoint": {
            "lat": 50.63391,
            "lon": 3.05512
          }
        },
        {
          "facility": "Hopital Trousseau",
          "city": "Paris",
          "country": "France",
          "geoPoint": {
            "lat": 48.85341,
            "lon": 2.3488
          }
        },
        {
          "facility": "University of Naples Federico II",
          "city": "Naples",
          "country": "Italy",
          "geoPoint": {
            "lat": 40.85216,
            "lon": 14.26811
          }
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "UNDECIDED"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D016269",
          "term": "Milk Hypersensitivity"
        }
      ],
      "ancestors": [
        {
          "id": "D005512",
          "term": "Food Hypersensitivity"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    }
  },
  "hasResults": false
}